WEREWOLF THERAPEUTICS INC. - COMMON STOCK

Werewolf Therapeutics to Present at the SVB Securities Global Biopharma Conference

07 2月 2023 07:00:00 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics Presents Preclinical Data on mWTX-330, a Surrogate IL-12 INDUKINE™ Molecule, at the Society for Immunotherapy of Cancer Annual Meeting

10 11月 2022 09:00:02 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update

10 11月 2022 07:00:01 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics to Present Preclinical Data at Society for Immunotherapy of Cancer Annual Meeting and Participate in Upcoming Investor Conferences

07 11月 2022 16:05:00 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference

07 9月 2022 07:00:01 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics Announces Initiation of Patient Dosing in Phase 1/1b Clinical Trial of WTX-124 for the Treatment of Patients with Selected Solid Tumors

01 9月 2022 07:00:01 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Highlights

11 8月 2022 07:00:03 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference

03 8月 2022 07:00:00 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference

06 6月 2022 16:51:01 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Highlights

10 5月 2022 07:00:02 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics Presents Promising Preclinical Data on its Two Lead INDUKINE™ Molecules at AACR 2022 Annual Meeting

08 4月 2022 13:00:00 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Provides Business Highlights

24 3月 2022 07:00:01 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics Announces Publication of Data Demonstrating the Preclinical Efficacy of WTX-124 in Delivering IL-2 Selectively to the Tumor Microenvironment

16 3月 2022 08:00:00 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics Announces Upcoming Presentations at AACR 2022 Annual Meeting

15 3月 2022 08:00:01 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics to Present at the SVB Leerink Global Healthcare Conference

08 2月 2022 08:00:01 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics to Present at the H.C. Wainwright Bioconnect Conference

05 1月 2022 08:00:02 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics Added to the Nasdaq Biotechnology Index

14 12月 2021 16:01:00 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics to Present Preclinical Data on INDUKINE™ Molecules at the 63rd American Society of Hematology (ASH) Annual Meeting

01 12月 2021 08:00:02 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics Reports Third Quarter 2021 Financial Results and Business Update

10 11月 2021 07:00:02 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics to Present at Upcoming Conferences in November 2021

08 11月 2021 08:03:15 条件 Nasdaq GlobeNewswire